Food and Drug Administration. FDA Drug Safety Communication: Safety review update of Chantix (Varenicline) and risk of neuropsychiatric adverse events. https://www.fda.gov/Drugs/DrugSafety/ucm276737.htm. Accessed January 17, 2018.
2.
AnthenelliRBenowitzNWestRet al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387:2507-2520. doi:10.1016/S0140-6736(16)30272-0.
3.
NaranjoCABustoUSellersEMet al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245. doi:10.1038/clpt.1981.154.
